top of page
target.png

Osta:
On
Site
Target
Activated

Our proprietary OSTA approach (On-Site-Target-Activated) acts as a triggerable Drug Delivery System (DDS) that get activated by the pathogens themselves. It delivers an active pharmaceutical ingredient when and where it is needed. It maximizes the therapeutic specificity and minimizes unnecessary systemic exposure.

We need new antibiotics,

not just more of the same

innovation OSTA.png

The OSTA innovation hijacks the defence mechanisms of pathogens to trigger, locally, the release of the active principle  (Trojan horse).

Novel first-in-class antibiotics

We develop new first-in-class antibiotics that target novel mechanisms and lead to no resistance.
Our active molecules are adapted from safe compounds for a maximum translatability to the clinic

attraction-molecules-1.jpg

The advantages of our smart OSTA molecules

SPECIFIC

specific2.png

Increased specificity against pathogenic and multi-resistant bacteria

BROAD ACTION

broad2.png

Broad antibacterial action against the main threatening pathogens

LONG-LASTING

no resistance2.png

Long-lasting action with no occurence of bacterial resistance

bottom of page